Web Analytics
MCK (NYSE) Stock Analysis | MCKESSON CORPORATION – Deepscope
MARKET

Select Market Data Region

MCK Stock Analysis — MCKESSON CORPORATION (Healthcare >> Medical Distribution)

MCK FAQ

What is MCK's P/E ratio?

MCKESSON CORPORATION (MCK) currently trades at a P/E ratio of 22.06.

What is MCK's ROE?

MCKESSON CORPORATION reports a Return on Equity (ROE) of -219.24%.

What is MCK's dividend yield?

MCKESSON CORPORATION offers a dividend yield of 0.36%.

What is MCK's Quality Score?

Our AI rates MCK's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MCK?

Our AI Timing Score for MCK is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MCK belong to?

MCKESSON CORPORATION is classified under the Healthcare >> Medical Distribution sector on the NYSE exchange

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-07-31 | FS: 2026-03-31)

MCK AI Analysis Summary

Our AI summary for MCK: MCKESSON CORPORATION (NYSE), Healthcare >> Medical Distribution sector. The stock currently trades at a P/E of 22.06, ROE of -219.24%, a dividend yield of 0.36%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MCK

MCKESSON CORPORATION
USD 856.19
-9.32 (-1.08%) Day Change
22.06
P/E
-3.14
D/E
-219.2%
ROE
5.8%
ROA
0.36%
Div Yield
10.21
PEG
USD 856.19
Price
-9.32 (-1.08%)
Day Change
NEWS SCORE: 99

MCK, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not good , ...

Quality Factors 50%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
1752
  Magic Formula Rank by ROE
1752
  Magic Formula Rank by ROIC
1031
  Price 856.19
  PBV / Sector
-125.96 / -7.19
  Earning Per Share 38.37
  PE / Sector
22.06 / 20.35
  PEG or PE/Growth / Sector
10.21 / 211.57
  Average 1M Daily Value
638.53 M
  Average 1W Daily Value
692.83 M
Timing Factors 71%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 47%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
1.18 / 3.85
  NPM Average (%) / Sector
1.09 / 2.56
  NPM Change Average (%) / Sector
-0.47 / -27.39
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
5.78 / 6.30
  ROA Average (%) / Sector
5.08 / 6.04
  ROA Change Average (%) / Sector
2.78 / -25.97
  ROE (%) / Sector
-219.24 / -27.59
  ROE Average (%) / Sector
-210.11 / -32.85
  ROE Change Average (%) / Sector
-1.70 / -32.92
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 12%
X
  Dividend (%) / Sector
0.36 / 0.39
  Dividend Average (%) / Sector
0.46 / 1.14
  Dividend Change Average (%) / Sector
-11.74 / -14.47
Registration Details
X
  Analyze Date 2026-08-01 08:00:09
  Symbol MCK
  Name MCKESSON CORPORATION
  Sector Healthcare >> Medical Distribution
  Market NYSE
  Listed Shares 117.08 M
  Par Value N/A
  Calculated From YearEnd
  Sign N/A
  Market Cap (M.USD) / Sector Average 105,054.51 / 45,764.92
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 6555 State Highway 161, Irving, TX, United States, 75039

Phone: 972 446 4800

Website: https://www.mckesson.com

Employees: 41,600

Sector: Healthcare >> Medical Distribution

Description: McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
10
10
10
Buy
3
3
3
Hold
3
3
3
Sell
1
1
1
Strong Sell
0
0
0
Consensus
Buy 4.29
Buy 4.29
Buy 4.29
Target Price
USD 990.87
USD 941.40
USD 945.47

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Medical Distribution

MCK (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

Stocks in the Same Sector

Healthcare › Medical Distribution

Analysed on the same criteria, ordered by market cap

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
MCK
MCK
USD 856.19 (-1.08%)
+ Watch + Port Chart